CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

Business Of Biotech - Podcast autorstwa Matt Pillar - Poniedziałki

Kategorie:

We love to hear from our listeners. Send us a message. Controlling the cost of personalized medicine: We go behind the scenes of the effort to build a system that simplifies production and reduces the cost of non-viral T cell therapies with Ziopharm Oncology CEO Laurence Cooper, M.D., Ph.D.Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch wit...

Visit the podcast's native language site